KLK OLEO-Davos Life Science
KLK OLEO – Davos Life Science, a leading market player in producing high-quality Tocotrienols and Palm Mixed Carotenes. These phytonutrients are functional ingredients for dietary supplements, foods and beverages, cosmetic and personal care products. Tocotrienols are potent antioxidants, rich in anti-inflammatory properties, essential for overall health and well-being. The Palm Mixed Carotenes are natural colouring agents with rich nutritional value and antioxidation benefits.
DavosLife E3 Tocotrienols
DavosLife E3 Tocotrienols, the next generation Vitamin E for overall health and well-being. It is produced from non-GMO palm fruit (Elaeis guineensis). DavosLife E3 contains complete spectrum natural Tocotrienols. This Super Vitamin E is potent natural antioxidant and rich in anti-inflammatory properties. Tocotrienols’ antioxidant properties are 60xmore powerful than α-tocopherol and up to 70x higher cellular uptake compared to α-tocopherol. Tocotrienols are scientifically proven for cardiovascular health, brain and nerve health, liver health, skin care and more. DavosLife E3, a functional ingredient for dietary supplement, functional foods & beverages, cosmetics and personal care products. It can be taken orally as a supplement or used in topical applications. DavosLife E3 complies with all major international regulatory standards on Persistent Organic Pollutants (POPs) and other contaminants in the standards for health supplements. Safety aAssessments conducted by the Cosmetic Ingredient Review (CIR) Expert Panel concluded that Tocotrienols are safe to use in cosmetics.
For online purchase of DavosLife softgel, visit www.klkoleo.com/davoslife/estore
DavoaLife Biocarotene is a natural mixed carotenes extracted from non-GMO palm fruit (Elaeis guineensis). DavoasLife Biocarotene contains predominantly α- and β-carotene that behave in a synergistic manner to provide health benefits beyond α-carotene and β-carotene individually. Compared to other source of market products, palm-based carotenes have the highest ratio of α-carotene to β-carotene. α- and β-carotene are scientifically proven to promote heart health, skin health, healthy aging, glucose metabolism, bone & joint health, cognitive health, eye health and more. DavosLife Biocarotene can be used in dietary supplements, including softgels and capsules. In food & beverage industries, DavosLife Biocarotene is used as natural colouring agents (E160a) with rich nutritional value and antioxidation benefits.
Other Natural Functional Ingredients
PALMESTER MCT (Oil/Powder)
PALMESTER MCT Oil (also known as Medium Chain Triglyceride) is a natural functional ingredient for food & beverage, nutrition, pharmaceutical, cosmetic & personal care products, and animal feed. It is an inert carrier for flavor, manufactured to the best bland taste for flavoring agents, to ensure excellent keeping quality and compatibility with sensitive flavors. Superb colorless properties for transparency and enhancing natural color; Miscible in more polar solvents such as alcohols, even in the presence of water; Good spreading properties for bakeries coating, mould release and lubricating production transport system; The superb color & odor makes it a good emollient for cosmetics & toiletries; Standard grade, produced to colorless, odorless and bland taste for food applications.
PALMESTER Triacetin (or Glyceryl Triacetate) is commonly used a plasticizer for cigarette filters, solvent for flavorings, general purpose food additive, raw material for food ester, etc.
PALMERA Glycerine is a highly versatile product which conforms to USP, EP & BP standards, making it suitable for wide range of applications such as food & beverage, nutrition, pharmaceutical, cosmetic & personal care applications.
- DavosLife E3 Tocotrienols
- DavosLife E3 Bio-Enhanced 20
- DavosLife E3 DVP 30 WD
- DavosLife Biocarotene Palm Mixed Carotenes
- PALMESTER MCT Oils (Caprylic Capric Triglyceride)
- PALMERA Glycerine (Pharma Grade)
- KOSTERAN Sorbitan Esters
- KOTILEN Sorbitan Ester Ethoxylates
- PALMESTER Triacetin
Use of tocotrienol composition for the prevention of cancer
In one aspect, the present invention relates to a composition comprising at least one of y-tocotrienol or 6-tocotrienol and (2R,3S)-N-carboxy-3-phenylisoserine, N-tert-butylester, 13-ester with 5,20-epoxy-1,2,4,7,10,13-hexahydroxytax-11-en-9one-4-acetate-2-benzoate, trihydrate (Docetaxel) and/or (5Z)-5(dimethylaminohydrazinylidene)imidazole-4-carboxamide (Dacarbazine).
In a further aspect, the present invention relates to a method of inhibiting or reversing of cancer by administering a composition comprising at least one of y-tocotrienol or 6-tocotrienol together with (2R,3S)-N-carboxy-N-tert-butylester-3phenylisoserine, 13-ester with 5,20-epoxy-1,2,4,7,10,13-hexahydroxytax-11-en-9one-4-acetate-2-benzoate, trihydrate (Docetaxel) and/or (5Z)-5(dimethylaminohydrazinylidene)imidazole-4-carboxamide (Dacarbazine).
Other aspects include uses and other methods of manufacturing a composition.
Patent Number: AU 2012209042 B2 | Patent Date: 08/23/2012
Formulation for effective tocotrienol delivery
The present invention disclosed a formulation in the form of self-emulsifying drug delivery formulation for improved delivery of tocotrienols comprising a fat-soluble compound, at least one emulsifier, and an oil carrier. The formulation shows an improved bioavailability of tocotrienols.
Patent Number: US20170326101A1 | Patent Date: 11/16/2017
Use of tocotrienol composition for the prevention of cancer
The present invention is directed to a method of preventing cancer or preventing the recurrence of cancer after undergoing a cancer treatment by administering a composition comprising at least one of ?-tocotrienol or d-tocotrienol, wherein the cancer is selected from the group consisting of melanoma, prostate cancer, prostate intraepithelial neoplasia, colon cancer, liver cancer, bladder cancer, breast cancer and lung cancer. The present invention is further directed to a composition comprising at least one of ?-tocotrienol or d-tocotrienol and Docetaxel and/or Dacarbazine, and to a method of inhibiting or arresting or reversing of cancer by administering a composition comprising at least one of ?-tocotrienol or d-tocotrienol together with Docetaxel and/or Dacarbazine. The present invention is also directed to methods of manufacturing those compositions.
Patent Number: US20110195910A1 | Patent Date: 08/11/2011
Synergistic interaction of at least one vitamin e component and tyrosinase inhibitors for dermatological applications
The present invention is directed to a method of treating a dermatological condition or preventing a dermatological condition from occurring or for altering the pigmentation of the skin by administering to a patient a pharmaceutically effective amount of a composition comprising at least one Vitamin E component and at least one additional component different from the Vitamin E component that has anti-tyrosinase activity and/or anti-melanogenesis activity. The present invention is further directed to a pharmaceutical composition comprising at least one Vitamin E component and at least one additional component different from the Vitamin E component that has anti-tyrosinase activity and/or anti-melanogenesis activity.
Patent Number: US20130317096A1 | Patent Date: 11/28/2013
Use of vitamin e isomers to treat respiratory diseases
The invention relates to the use of Vitamin E and, particularly, isomers thereof to treat respiratory diseases such as, but not limited to, obstructive/restrictive airway disorders, asthma, chronic obstructive pulmonary disease, bronchitis, fibrosis, respiratory distress syndrome, and other inflammatory lung diseases; a method of treating said diseases employing the use of Vitamin E and, particularly, isomers thereof; a combination therapeutic comprising said Vitamin E and, particularly, isomers thereof, and at least one other therapeutic or bioactive molecule, for treating respiratory diseases; a composition or supplement comprising Vitamin E and, particularly, isomers thereof; and an inhaler comprising Vitamin E and, particularly, isomers thereof for treating respiratory diseases.
Patent Number: WO2014175826A1 | Patent Date: 10/30/2014
Use of tocotrienols in the treatment or prevention of ulcerative colitis
The present invention is directed to a method of treating ulcerative colitis or preventing ulcerative colitis from occurring or reoccurring by administering to a patient a pharmaceutically effective amount of a composition comprising at least one tocotrienol, wherein the composition comprises the at least one tocotrienol in an amount that is pharmaceutically effective for the treatment and/or prevention of ulcerative colitis.
Patent Number: WO2015060789A1 | Patent Date: 04/30/2015
DavosLife E3 Tocotrienols
Palm Mixed Carotenes
Medium Chain Triglycerides (or Caprylic Capric Triglyceride)
PALMESTER MCT Oil